Basepoint Wealth’s Clorox CLX Stock Holding History

Basepoint Wealth’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.3K	Buy	177 +1	+0.6%	+$113	0.01%	340
2025 Q4	$17.8K	Buy	+176	New	+$19.1K	0.01%	339

Other funds holding CLX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Basepoint Wealth's CLX Position: Q1 2026 in Review

Basepoint Wealth increased its Clorox (CLX) stake by 0.57% in Q1 2026, buying an estimated $113 and bringing the position to 177 shares worth $18.3K. The position accounts for 0.01% of the portfolio, ranked #340.

Basepoint Wealth first reported a position in CLX in Q4 2025 and has held it in 2 quarters since. 1,081 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

Basepoint Wealth held 177 shares of Clorox worth $18.3K as of Q1 2026.
Basepoint Wealth bought 1 Clorox share in Q1 2026, an estimated $113.
Clorox made up 0.01% of Basepoint Wealth's portfolio in Q1 2026, its #340 holding.
Basepoint Wealth first reported a position in Clorox in Q4 2025 and has held it in 2 quarters since.
1,081 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.